AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
+4.69%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$132M
AUM Growth
+$132M
(+17%)
Cap. Flow
+$9.93M
Cap. Flow
% of AUM
7.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Cogent Biosciences
COGT
|
$37.3M |
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
$27.4M |
Sector Composition
| 1 | Healthcare | 98.2% |
| 2 | Communication Services | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Intellia Therapeutics
NTLA
$1.22B
| $48.1M | 36.34% |
2,279,788
-1,300,000
| -36% | -$27.4M |
|
|
2
Cogent Biosciences
COGT
$1.68B
| $37.3M | 28.23% |
+3,361,535
| New | +$37.3M |
|
3
Synlogic
SYBX
$17.1M
| $24.9M | 18.8% |
2,651,963
| – | – |
|
4
Spero Therapeutics
SPRO
$115M
| $19.6M | 14.83% |
1,376,968
| – | – |
|
5
Snap
SNAP
$12.4B
| $2.38M | 1.8% |
150,160
| – | – |
|